Schedule 13D ownership disclosure
INHIBIKASE THERAPEUTICS INC
Security class unavailable · CUSIP: 45719W106
Event date: 2023-01-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,517,000
- Percent of class
- 4.1200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001513162-23-000013
- Form type
- SC 13D
- Filer
- FiveT Investment Management Ltd
- CIK
- CIK 1846823
- Filed
- Jan 31, 2023
- Reporting period
- Jan 25, 2023
- Description
- Schedule 13D beneficial ownership